about
CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureyleneSerum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureyleneIL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasisDose modeling in ultraviolet phototherapyPharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.The role of salicylic acid in the treatment of psoriasis.Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study.CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial.Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease. Viewpoint.Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACHThe Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital.Biologics in the management of psoriasis.ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression.Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort studyStudy on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis.Peroxisome proliferator-activated receptor-beta as a target for wound healing drugs.HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.Pediatric psoriasis and psoriatic arthritis.Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments.The Advantage of Cyclosporine A and Methotrexate Rotational Therapy in Long-Term Systemic Treatment for Chronic Plaque Psoriasis in a Real World Practice.Novel immunobiologics for psoriasis.Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkersTreatment of psoriasis and psoriatic arthritis.Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response.Treatment of psoriasis: focus on clinic-based management with infliximab.JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis.Psoriasis treatment and management - a systematic review of full economic evaluations.Role of Wnt5a in the Pathogenesis of Inflammatory Diseases.Investigations of cabin design in UV phototherapy.Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis VulgarisSystemic treatment of severe psoriasis.Resistant palmoplantar lesions in patients of psoriasis: evaluation of the causes and comparison of the frequency of delayed-type hypersensitivity in patients without palm and sole lesions.Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09.
P2860
Q24791832-7ED8A0B9-21E3-4942-A0D1-CD559573E107Q24803476-30870A35-236B-4230-9C6D-27F1D8DF47C7Q28268370-5B7D4395-0BA9-4629-8DA7-C4726B3C880AQ28298735-06AFEFE3-CF13-49FD-A170-7CA445DED59AQ30977623-B14173D0-9E19-4295-A30F-10B050CFEFC0Q31029459-D30FD915-E780-478B-94F5-4B6E8A677CADQ33538275-5886BBF5-A1AD-4C8E-A679-47864EAC61FFQ33794253-D0D6F103-971A-48DD-9FAE-AF0C25DE0F08Q33855058-38F0BF80-EFE1-4D05-89DD-F525573DAC20Q33902313-2292653A-55AF-4A9D-A8DD-1DD943F7D70DQ34038554-010BE91A-E4DB-40FA-84AF-4930496FFA0DQ34135765-A2A4BAE0-571D-4550-93F1-144EAD088D80Q34497018-F066E138-39F3-4B7F-8EF4-B2DACFC2FB34Q34610079-F03DACFF-D151-48DB-ADA5-35A52D0120F0Q34620257-6CBE4BA2-D698-4A17-B91C-E49F7892B9D8Q34648662-797BAEE1-4BC5-4501-827B-AEF197CA9CBFQ34956195-9124D4F7-48F4-4A4A-9325-0BB7B6E3ABDFQ35096973-284ECBD7-EBC4-483B-8A62-4C656A68D6AEQ35680560-815EC85D-B0B0-4FAD-90C8-24D09977BC0BQ35746565-C83114AF-B06F-4367-B169-D860D6B4D06AQ35817223-ABC3A5C0-4D18-49DC-B57C-E4C7AF06A6AEQ35893141-B2670820-EA2E-47A0-8868-5ECFEAB4857DQ36534231-423D2A44-015F-4514-8EB4-088484D6C068Q37654044-DF4300F3-15E0-4B37-ABA0-72847BAE8A26Q37664478-404CEFBE-F1C5-4B0C-B939-293ACCFBADA0Q37961072-455B9A45-6FA2-4326-A053-908A8F611B83Q38083084-149A3BDC-0F17-4269-A926-996E412BB6F0Q38132706-0E603A93-6CD5-4A11-832A-21E6894E9F7EQ38152820-DD208DEB-2BC6-44AD-9FBD-92670019E70FQ38207916-D223F896-D7D0-4DB6-AA10-B83810908DCFQ38216654-3E42AFCD-F072-4840-8601-493F760216FFQ38260967-E8C2464D-F211-4BF2-81C7-FE5DD8D3E7D9Q39012183-F32E5DF4-7558-450E-80CE-9D044B4E973BQ39592466-2A45B52D-E5DD-4169-9E98-C0E8B753CFCCQ40017163-1548A568-D3A8-4CB8-9E5A-19E1A3D54466Q41459506-A9EBD5FF-450D-4D90-9D83-4074ACB5458BQ41460287-410EE3F8-507E-48FA-B974-00C3FABE2E7DQ41683565-4DCA8B0A-582E-4B3D-94CA-62C74AF85D38Q41750724-00F27B43-166C-4CA3-A2A8-16332B59327EQ42240106-F5D2FC3D-8730-4A9A-ABC2-80E8C259D952
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Treatment of psoriasis.
@en
type
label
Treatment of psoriasis.
@en
prefLabel
Treatment of psoriasis.
@en
P1476
Treatment of psoriasis.
@en
P2093
Greaves MW
Weinstein GD
P304
P356
10.1056/NEJM199503023320907
P407
P577
1995-03-01T00:00:00Z